Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liquidia Technologies Inc

12.19
+0.13001.08%
Post-market: 12.300.1100+0.90%16:23 EDT
Volume:1.03M
Turnover:12.46M
Market Cap:1.04B
PE:-7.13
High:12.30
Open:12.10
Low:11.89
Close:12.06
Loading ...

Liquidia Technologies (LQDA) Gets a Buy from Raymond James

TIPRANKS
·
03 Jun

Liquidia price target raised to $32 from $25 at Needham

TIPRANKS
·
02 Jun

Liquidia Corp - Court Denies United Therapeutics’ Injunction Request, Clears Path for Yutrepia Launch

THOMSON REUTERS
·
02 Jun

Court Denies United Therapeutics' Injunction Request, Paving the Way for Liquidia's YUTREPIA Launch

Reuters
·
02 Jun

Liquidia Is Maintained at Buy by Needham

Dow Jones
·
02 Jun

Liquidia Technologies (LQDA) Receives a Buy from LifeSci Capital

TIPRANKS
·
31 May

These Analysts Boost Their Forecasts On Liquidia

Benzinga
·
28 May

Liquidia price target raised to $37 from $36 at Scotiabank

TIPRANKS
·
28 May

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

Reuters
·
28 May

Liquidia Price Target Maintained With a $25.00/Share by Needham

Dow Jones
·
28 May

Liquidia Technologies (LQDA) Receives a Buy from Wells Fargo

TIPRANKS
·
28 May

Hold Rating for United Therapeutics Amid Competitive Pressures from LQDA’s Yutrepia

TIPRANKS
·
28 May

Jefferies Lifts Liquidia Technologies' Price Target to $31 From $27, Buy Rating Kept

MT Newswires Live
·
28 May

Liquidia price target raised to $31 from $27 at Jefferies

TIPRANKS
·
28 May

Analysts Conflicted on These Healthcare Names: Globus Medical (GMED) and Liquidia Technologies (LQDA)

TIPRANKS
·
27 May

Liquidia price target raised to $25 from $22 at BofA

TIPRANKS
·
27 May

Liquidia Receives FDA Approval on Yutrepia for Treatment of Pulmonary Hypertension

MT Newswires Live
·
24 May

Liquidia Technologies trading resumes

TIPRANKS
·
24 May

Liquidia announces FDA approval of Yutrepia

TIPRANKS
·
24 May

FDA Approves Liquidia's YUTREPIA for Pulmonary Hypertension, Paving Way for Commercial Launch

Reuters
·
24 May